Part of a comprehensive analysis of the Human Biomedical Research Act 2015
All Parts in This Series
Human Biomedical Research Act 2015: Key Provisions and Their Purpose
The Human Biomedical Research Act 2015 (HBRA) serves as the foundational legal framework governing biomedical research involving human subjects in Singapore. Part 1 of the Act, titled "Preliminary," lays down the essential groundwork by defining the scope, key terms, and the nature of human biomedical research regulated under the Act. Understanding these provisions is critical because they establish the boundaries within which biomedical research must be conducted, ensuring ethical standards, legal compliance, and protection of research subjects.
"This Act is the Human Biomedical Research Act 2015." — Section 1
Verify Section 1 in source document →
Purpose: Section 1 formally enacts the legislation, providing the Act’s short title. This is a standard legislative provision that ensures clarity and ease of reference in legal and administrative contexts.
"In this Act, unless the context otherwise requires —" followed by definitions of key terms such as "adult," "biomedical research," "human biomedical research," "research institution," etc. — Section 2
Verify Section 2 in source document →
Purpose: Section 2 is a comprehensive definitions clause that clarifies the meaning of critical terms used throughout the Act. This is essential to avoid ambiguity and to ensure consistent interpretation and application of the law. For example, defining "adult" as "a person who is 21 years of age or older or a person below 21 years of age who was or is married" sets a clear age threshold relevant for consent and capacity considerations.
"In this Act, 'human biomedical research' means the research specified in subsection (2) or (3) but subject to subsection (4)." — Section 3(1)
Verify Section 3 in source document →
Purpose: Section 3 establishes the legal definition of "human biomedical research," which is pivotal because the Act’s regulatory regime applies specifically to this category of research. The detailed subsections (2) to (5) further delineate what constitutes such research and the conditions under which it must be conducted, including the supervision by a research institution. This ensures that research involving human participants or their biological materials is conducted responsibly and ethically.
Definitions in Part 1: Clarifying the Legal Landscape
The Act’s definitions in Section 2 are extensive and cover a wide range of terms that are fundamental to the regulation of biomedical research. These definitions serve to provide precision and legal certainty, which are necessary for effective enforcement and compliance.
"In this Act, unless the context otherwise requires — 'adult' means a person who is 21 years of age or older or a person below 21 years of age who was or is married; ... 'tissue banking activity' means a structured and an organised activity involving human tissue for the purposes of facilitating current or future research or for public health or epidemiological purposes or any combination of such purposes including any of the following activities: (a) the collection, storage, procurement or importation of human tissue; (b) the supply, provision or export of human tissue." — Section 2
Verify Section 2 in source document →
Purpose: The inclusion of terms such as "adult," "tissue banking activity," and others like "biomedical research," "research institution," and "research subject" ensures that all stakeholders—researchers, institutions, regulators, and participants—have a shared understanding of the terminology. This reduces the risk of misinterpretation and helps delineate the scope of the Act’s application.
Penalties for Non-Compliance: Absence in Part 1
It is notable that Part 1 of the Human Biomedical Research Act 2015 does not specify any penalties for non-compliance. This is consistent with the purpose of Part 1 as a preliminary section focused on definitions and scope rather than enforcement mechanisms.
No penalties are mentioned in Part 1 PRELIMINARY.
Verify source in source document →
Purpose: The absence of penalties in this Part reflects the legislative design where enforcement provisions, including penalties, are typically set out in later parts of the Act. This separation ensures that the foundational definitions and scope are clearly established before addressing compliance and sanctions.
Cross-References to Other Legislation: Ensuring Legal Cohesion
The Human Biomedical Research Act 2015 cross-references several other key statutes to ensure coherence and integration within Singapore’s broader legal framework. These include the Mental Capacity Act 2008, Healthcare Services Act 2020, and Medical Registration Act 1997.
"'adult who lacks mental capacity' means an adult who lacks capacity within the meaning of section 4 of the Mental Capacity Act 2008;" — Section 2
Verify Section 2 in source document →
"'deputy', in relation to an adult who lacks mental capacity, means a deputy appointed by the court under the Mental Capacity Act 2008;" — Section 2
Verify Section 2 in source document →
"'lasting power of attorney' means a valid lasting power of attorney registered under the Mental Capacity Act 2008;" — Section 2
Verify Section 2 in source document →
"'healthcare institution' means — (a) the holder of a licence granted under the Healthcare Services Act 2020; or (b) any facility, premises or conveyance which is declared by the Minister, by order in the Gazette, to be a healthcare institution for the purposes of this Act;" — Section 2
"'medical practitioner' means a person who is registered, or deemed to be registered, as a medical practitioner under the Medical Registration Act 1997;" — Section 2
Verify Section 2 in source document →
Purpose: These cross-references serve multiple functions:
- Legal Consistency: By adopting definitions and concepts from related legislation, the HBRA ensures consistency in legal interpretation and application across different statutes.
- Protection of Vulnerable Persons: References to the Mental Capacity Act 2008 are crucial for safeguarding adults who lack mental capacity, ensuring that their participation in biomedical research is ethically and legally appropriate.
- Regulatory Integration: Linking to the Healthcare Services Act 2020 and Medical Registration Act 1997 aligns the regulation of research institutions and medical practitioners with existing healthcare regulatory frameworks.
Conclusion
Part 1 of the Human Biomedical Research Act 2015 establishes the foundational legal framework necessary for regulating biomedical research involving human subjects in Singapore. By defining key terms, setting the scope of regulated research, and integrating with other relevant legislation, this Part ensures clarity, legal certainty, and ethical oversight. Although it does not address penalties, its provisions are indispensable for the effective implementation and enforcement of the Act’s broader objectives.
Sections Covered in This Analysis
- Section 1 – Short Title
- Section 2 – Interpretation (Definitions)
- Section 3 – Human Biomedical Research: Definition and Scope
Source Documents
For the authoritative text, consult SSO.